₩28,750.00 ($21.40)

+750.00 (+2.68%)

Weekly Expected Move ±4.9%

₩25943 ₩27346 ₩28750 ₩30154 ₩31557

KOE · Healthcare · Medical - Devices · Tech Score Buy · Power 61 · ₩248.7B mcap · 8M float · 0.411% daily turnover

Revenue

$239.3B +7.4% ▲

5Y CAGR: +8.4%

Gross Profit

$96.9B +1.4% ▲

5Y CAGR: +3.8%

Operating Income

$21.4B +2.4% ▲

5Y CAGR: -5.9%

Net Income

$22.0B +3.2% ▲

5Y CAGR: -0.8%

EPS (Diluted)

$2234.08 -3.7% ▼

5Y CAGR: -1.4%

EBITDA

$29.7B -16.1% ▼

5Y CAGR: -1.4%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$193.1B	$237.9B	$220.3B	$222.9B	$239.3B
YoY Growth	+20.5%	+23.2%	-7.4%	+1.2%	+7.4%
Cost of Revenue	$99.7B	$131.5B	$125.0B	$127.3B	$142.4B
Gross Profit	$93.4B	$106.4B	$95.3B	$95.6B	$96.9B
Gross Margin	48.4%	44.7%	43.3%	42.9%	40.5%
R&D Expenses	$22.9B	$22.8B	$26.9B	$26.1B	$0
SG&A Expenses	$13.6B	$16.6B	$18.1B	$20.1B	$0
Operating Expenses	$60.6B	$64.1B	$76.6B	$73.3B	$75.6B
Operating Income	$34.8B	$43.7B	$18.7B	$20.9B	$21.4B
Operating Margin	18.0%	18.3%	8.5%	9.4%	8.9%
Interest Expense	$388M	$1.1B	$2.5B	$2.3B	$1.4B
Income Before Tax	$39.7B	$33.1B	$17.0B	$25.6B	$25.3B
Tax Expense	$6.1B	$6.6B	$1.9B	$4.5B	$4.4B
Net Income	$33.5B	$26.5B	$14.7B	$21.3B	$22.0B
Net Margin	17.3%	11.2%	6.7%	9.6%	9.2%
EPS (Diluted)	$3575.35	$2890.32	$1602.58	$2319.40	$2234.08
EBITDA	$45.6B	$40.7B	$26.2B	$35.4B	$29.7B
Shares Outstanding	9M	9M	9M	9M	9M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$48.4B	$59.7B	$54.4B	$62.7B	$53.7B	$68.6B	$58.2B	$63.9B
Cost of Revenue	$27.8B	$33.2B	$31.6B	$36.2B	$31.8B	$40.2B	$31.2B	$33.4B
Gross Profit	$20.6B	$26.6B	$22.8B	$26.5B	$21.8B	$28.4B	$27.0B	$30.5B
Gross Margin	42.5%	44.5%	41.9%	42.2%	40.7%	41.4%	46.4%	47.7%
R&D Expenses	$6.2B	$6.5B	$0	$6.3B	$4.7B	$8.1B	$5.6B	$0
SG&A Expenses	$4.7B	$5.9B	$6.9B	$20.0B	$4.8B	$4.9B	$5.8B	$4.2B
Operating Expenses	$16.0B	$19.6B	$20.7B	$20.0B	$17.5B	$20.0B	$18.1B	$19.7B
Operating Income	$4.5B	$6.9B	$2.1B	$6.5B	$4.3B	$8.5B	$8.8B	$10.8B
Operating Margin	9.4%	11.6%	3.8%	10.4%	8.0%	12.4%	15.2%	16.9%
Interest Expense	$308M	$815M	$471M	$528M	$352M	$99M	$1.2B	$604M
Income Before Tax	$654M	$11.7B	$2.7B	$2.8B	$7.6B	$12.3B	$10.9B	$17.5B
Tax Expense	-$513M	$2.5B	$584M	$826M	$1.2B	$1.8B	$1.6B	$1.3B
Net Income	$1.3B	$9.2B	$2.3B	$2.1B	$6.7B	$10.8B	$9.5B	$16.4B
Net Margin	2.7%	15.5%	4.3%	3.4%	12.4%	15.8%	16.4%	25.7%
EPS (Diluted)	$140.13	$1006.05	$254.74	$237.00	$743.00	$1118.80	$1070.00	$1906.55
EBITDA	$2.8B	$14.5B	$5.3B	$28.6B	$10.1B	$10.4B	$11.1B	$12.7B
Shares Outstanding	9M	9M	9M	9M	9M	9M	9M	9M

100120.KQ KOE